ClinicalTrials.Veeva

Menu

Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa

University of Virginia logo

University of Virginia

Status

Completed

Conditions

Environmental Exposure
Malnutrition, Child
Diarrhoea;Infectious;Presumed
Enteropathy
Diarrhea Tropical
Diarrhea, Infantile

Treatments

Device: Safe-storage water container
Device: Silver-impregnated ceramic water filter
Device: Silver-impregnated ceramic tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT03012048
IRB-HSR 18662

Details and patient eligibility

About

This project is a community-based randomized controlled trial designed to test the effectiveness of two point-of-use water treatment technologies to improve clean drinking water access, reduce enteropathogen burden, and improve child growth among children in Limpopo, South Africa.

Full description

Lack of access to safe water in low-resource settings likely contributes to stunted growth early in life, which affects more than a quarter of children under 5 years worldwide. Point-of-use water treatment technologies have the potential to provide effective and low-cost solutions to improving quality of drinking water in these settings. One such technology, a silver-impregnated ceramic disk, continually disinfects water in household water storage containers by diffusing silver into the water for daily treatment of 10 to 15 liters for at least six months. Silver-impregnated ceramic water filters are another commercially available technology that additionally remove pathogens mechanically. While both technologies have proven to be highly effective in treating water, it is unknown whether the use of these technologies will translate to improvements in child health outcomes. This community-based intervention trial will estimate the effect of the silver-impregnated ceramic disk and a silver-impregnated ceramic water filter on linear growth of children in Limpopo, South Africa.

Households in the Dzimauli community will be randomized to receive the ceramic disk, a water filter, the safe-storage water container alone, or no intervention. Children will be followed every three months for 2 years to assess height, weight, and pathogen burden in stool samples. Cognitive assessments will be completed at 2, 5, and 7 years of follow-up. The investigators hypothesize that children in households given the ceramic disk or the water filter will show improved linear growth compared to those in households without these interventions. The investigators expect that the ceramic disk will perform similarly to the water filter and result in similar improvements in linear growth when compared to children from control households.

Estimates of effectiveness demonstrated in this trial will provide the necessary evidence base to support the scale-up of manufacturing and distribution of the ceramic disks and filters, which could provide a robust point-of-use water treatment solution for rural areas. By helping to identify effective tools to reduce the risk of stunting in children, the trial will contribute to targets to improve child health in low-resource settings.

Enrollment

415 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Mother is in third trimester of pregnancy or there is at least one child under 3 years of age in the household
  • The child's caregiver is at least 16 years of age

Exclusion criteria

  • The household has chlorinated water piped into the home or routinely delivered (via truck or diversion) to a permanent, engineered system that stores the water within the property
  • The household currently uses a ceramic filter or other commercial water treatment technology (including a permanent, engineered system that treats the water through filtration and/or chlorination)
  • The household has plans to move outside the community in the next 6 months
  • The youngest child under 3 years of age is seriously ill (has a severe disease requiring prolonged hospitalization or a severe or chronic condition diagnosed by medical doctor, e.g. neonatal disease, renal disease, chronic heart failure, liver disease, cystic fibrosis, congenital conditions)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

415 participants in 4 patient groups

MadiDrop (ceramic tablet)
Experimental group
Description:
Households receive a MadiDrop (silver-impregnated ceramic tablet) in a safe-storage water container to use for all drinking water needs in the household. MadiDrops are replaced every 6 months over the 2-year intervention study period. In July 2017, all households in the MadiDrop arm were crossed over to the ceramic water filter arm due to inconsistent silver release from the ceramic tablets.
Treatment:
Device: Silver-impregnated ceramic tablet
Silver-impregnated ceramic water filter
Active Comparator group
Description:
Households receive a silver-impregnated ceramic filter in a safe-storage water container to use for all drinking water needs in the household. Filters are replaced at the end of the 2-year intervention study period. In December 2017, all silver-impregnated ceramic water filters were replaced with the same ceramic filters without silver due to continued inconsistencies with silver release.
Treatment:
Device: Silver-impregnated ceramic water filter
Safe-storage water container
Active Comparator group
Description:
Households receive a safe-storage water container alone to use for all drinking water needs in the household.
Treatment:
Device: Safe-storage water container
No intervention
No Intervention group
Description:
Households are encouraged to continue their usual water treatment practices.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems